Saturday, September 26, 2026
MiningNewsTerminal
Saturday, September 26, 2026 Admin

IFOS.V ·

Itafos Reports Q2 2023 Results

Financials

TSX-V: IFOS

News Release

ITAFOS REPORTS Q2 2023 RESULTS

HOUSTON, TX – August 9, 2023 – Itafos Inc. (TSX-V: IFOS) (the “Company”) repo rted today its Q2 2023 financial and operational

highlights. The Company’s financial statements and management’s discussion and analysis for the three and six months ended June 30,

2023 are available under the Company’s profile at www.sedarplus.com and on the Company’s website at www.itafos.com. All figures are

in thousands of US Dollars except as otherwise noted.

CEO Commentary

“We are pleased to report solid financial results and continuat ion of our strong safety and operational performance in Q2 2023. For 1H

2023 we reported revenues of $235.7 million and adjusted EBITDA of $82.6 million.

The Record of Decision issued on April 24th and subsequent Notice to Proceed on May 8th for the Husky 1/North Dry Ridge mine project

represent a significant milestone for Itafos. The approvals provide the pa th for the Company to ach ieve our strategic goal of e xtending

Conda’s mine life. The permit allows us to work to continue to serve the North American fertilizer market through 2037 with pot ential to

further extend the resource life through leases and third-party arrangements.

The Company has lowered its full year EBITD A guidance, due to the sharp decline in comm odity prices in Q2. The impact of this p rice

decline will also be seen in the Company’s Q3 performance due to th e pricing formula of our MAP sales contract. Following the s harp

decline in Q2, commodity prices have partially rebounded in ear ly Q3, driven by demand improvement and tighter US supply

fundamentals.”

Finally, the process to explore and evaluate various strategic alternatives to enhance value for all Itafos Shareholders announced by our

Board in Q1 2023 is on-going. At the same time, we remained fo cused on running the Company to support our customers, maintaining

our safety performance, and delivering on our operational and financial results” said G. David Delaney, CEO of Itafos.

Q2 2023 Key Highlights

 revenues of $116.1 million

 Adjusted EBITDA of $39.7 million 1

 net income of $20.4 million

 basic earnings of C$0.14/share

 free cash flow of $44.1 million 1

H1 2023 Key Highlights

 revenues of $235.7 million

 Adjusted EBITDA of $82.6 million

 net income of $48.6 million

 basic earnings of C$0.35/share

 free cash flow of $63.9 million

June 30, 2023 Key Highlights

 trailing 12 months Adjusted EBITDA of $183.4 million 1

 net debt of $38.0 million 1

 net leverage ratio of 0.2x 1

1 Adjusted EBITDA, trailing 12 months Adjusted EBITDA, maintenanc e capex, growth capex, net debt, net leverage ratio and free cas h flow are each a

non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures” below. International

Financial Reporting Standards (“IFRS”).

Lowered FY 2023 Guidance

 Adjusted EBITDA guidance of $115-135 million

 net income guidance of $45-60 million

 basic earnings guidance of C$0.31-0.41/share

 maintenance capex guidance of $15-25 million 1

 growth capex guidance of $35-45 million 1

 free cash flow guidance of $65-85 million

Q2 and H1 2023 Market Highlights

Diammonium phosphate ("DAP") New Orleans ("NOLA") prices avera ged $527/st in Q2 2023 compared to $860/st in Q2 2022, down

39% year-over-year, and averaged $571/st in H1 2023 compared to $82 7/st in H1 2022, down 31% ye ar-over-year. Specific factors

driving the year-over-year decline in DAP NOLA were as follows:

 weakened demand in response to historically high 2022 phosphate prices;

 the softening of global Ammonia and Sulphur prices;

 the softening of historically high crop prices; and

 increased phosphate exports out of Russia and China.

Q2 2023 Financial Highlights

For Q2 2023, the Company’s financial highlights were as follows:

 revenues of $116.1 million in Q2 2023 compared to $155.0 million in Q2 2022;

 Adjusted EBITDA of $39.7 million in Q2 2023 compared to $63.6 million in Q2 2022;

 net income of $20.4 million in Q2 2023 compared to $44.3 million in Q2 2022;

 basic earnings of C$0.14/share in Q2 20 23 compared to C$0.30/share in Q2 2022; and

 free cash flow of $44.1 million in Q2 2023 compared to $41.3 million in Q2 2022.

The decrease in the Company’s Q2 2023 financial performance compar ed to Q2 2022 was primarily due to lower realized prices as a

result of softer global market conditions partially offset by lower input costs.

The Company’s total capex2 spend in Q2 2023 was $18.1 million compared to $16.0 mi llion in Q2 2022 with the increase primarily due

to the the development actvities at H1/NDR upon receipt of ROD in Q2 2023.

H1 2023 Financial Highlights

For H1 2023, the Company’s financial highlights were as follows:

 revenues of $235.7 million in H1 2023 compared to $304.9 million in H1 2022;

 Adjusted EBITDA of $82.6 million in H1 2023 compared to $124.0 million in H1 2022;

 net income of $48.6 million in H1 2023 compared to $77.3 million in H1 2022;

 basic earnings of C$0.35/share in H1 2023 compared to C$0.52/share in H1 2022; and

 free cash flow of $63.9 million in H1 2023 compared to $95.7 million in H1 2022.

The decrease in the Company’s H1 2023 financial performance comp ared to H1 2022 was primarily due to lower sales volumes and

lower realized prices, partially offset by lower input costs.

The Company’s total capex2 spend in H1 2023 was $20.9 million compared to $21.3 million in H1 2022 with the decrease primarily due

to the capital additions expended in the prior year relating to the HFSA build out at Conda during Q1 2022 and the Arraias sulf uric acid

restart.

2Total capex is a non-IFRS financial measur e. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures”

below.

June 30, 2023 Highlights

As at June 30, 2023, the Compan y had trailing 12 months Adjusted EBITDA of $183. 4 million compared to $224.8 million at the end of

2022 with the decrease primarily due to the same factors that resulted in lower revenues, which were partially offset by lower input costs

at Conda.

At June 30, 2023, the Company had net debt of $38.0 million compared to $88.3 million at the end of 2022, with the reduction due to the

repayment of principal debt outstanding from free cash flows generated and higher cash and cash equivalents. The Company’s net debt

as at June 30, 2023 was comprised of $68.6 million in cash and $106.6 million in debt (gross of deferred financing costs). As at June 30,

2023 and the end of 2022, the Company’s net leverage ratio were 0.2x and 0.4x.

As at June 30, 2023, t he Company had liquidity 3 of $101.7 million comprised of $68.6 million in cash and $33.0 million in ABL Facility

undrawn borrowing capacity.

Q2 2023 Operational Highlights

Environmental ,Health, and Safety ("EHS")

 Sustained EHS performance, including no re portable environmental releases and two recordable incidents, which resulted in a

consolidated total recordable incident frequency rate ("TRIFR") of 0.35.

Conda

 Produced 83,190 tonnes P 2O5 at Conda in Q2 2023 compared to 80,297 tonnes P 2O5 in Q2 2022 with the increase primarily

due to higher throughput resulting from operational efficiencies and reduced downtime;

 Generated revenues of $112.9 million at Conda in Q2 2023 co mpared to $148.9 million in Q2 2022 primarily due to lower realized

prices;

 Generated Adjusted EBITDA at Co nda of $44.6 million in Q2 2023 compared to $ 66.7 million in Q2 2022 primarily due to the

same factors that resulted in lower revenues, which were partially offset by lower input costs;

 On April 24, 2023, the Company announced the Record of De cision ("ROD") for Husky 1/North Dry Ridge ("H1/NDR") mine

development project. The H1/NDR project comp rises primarily of civil activities and infrastructure development. Mineral

resources from H1/NDR are expected from 20264 onward, providing an uninterrupted supply as Rasmussen Valley Mine reaches

the end of its useful life; and

 On May 8, 2023, the Company received the Notice of Proc eed ("NTP") for H1/NDR mine development project. Upon receipt of

the NTP, the Company has begun capital activities associated with the mine development project.

Q2 2023 Other Highlights

 Produced 8,523 tonnes of sulfuric acid at Arraias in Q2 2023 compared to 20,549 tonnes in Q2 2022 with the decrease due to

sulfuric acid plant shutdown for required maintenance and turnaround in June 2023;

 Generated Adjusted EBITDA at Arraias of $0.8 million loss in Q2 2023 compar ed to $0.4 million gain in Q2 2022 with the

decrease primarily due to lower realized sulfur ic acid prices, which were partially offs et by higher sales volumes, lower cost of

goods sold and lower selling, general and administrative expenses;

 On June 28, 2023, the Company filed the National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-

101”) technical report for the Farim Phosphate Project; and

 The Special Committee of the Board of Directo rs continues to evaluate strategic alternatives that may be available to company

in an effort to enhance shareholder value.

3 Liquidity is a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures”

below.

H1 2023 Operational Highlights

Environmental, Health, and Safety ("EHS")

 Sustained EHS excellence, including no reportable environmental releases and two recordable incidents, which resulted in a

consolidated total recordable incident frequency rate ("TRIFR") of 0.35.

Conda

 Produced 165,336 tonnes P 2O5 at Conda in Q2 2023 compared to 169,393 tonnes P 2O5 in Q2 2022 with the decrease slightly

due to extreme winter weather conditions and unplanned downtime in Q1 2023, mostly offset by stronger throughput in Q2 2023;

 Generated revenues of $228.9 million at Conda in Q2 2023 com pared to $296.5 million in Q2 2022 primarily due to lower sales

volumes and lower realized prices;

 Generated Adjusted EBITDA at Co nda of $92.0 million in Q2 2023 compared to $131.1 million in Q2 2022 primarily due to the

same factors that resulted in lower revenues, which were partially offset by lower input costs;

 On April 24, 2023, the Company announc ed the ROD for H1/NDR mine development project. The H1/NDR project comprises

primarily of civil activities and infrastructure devel opment. Mineral resources from H1/NDR are expected from 2026 4 onward,

providing an uninterrupted supply as Rasmussen Valley Mine reaches the end of its useful life; and

 On May 8, 2023, the Company received t he NTP for H1/NDR mine development project. Upon receipt of the NTP, the Company

has begun capital activities associated with the mine development project.

H1 2023 Other Highlights

 Produced 29,137 tonnes of sulfuric acid at Arraias in H1 2023 compared to 30,200 tonnes in H1 2022 with the Sulfuric acid

production consistent year-over-year; Increased sales volumes due to full half year sales in H1 2023 compared to a partial half

year in H1 2022 (the sulfuric acid plant was restarted in February 2022);

 Generated Adjusted EBITDA at Arraias of $0 .6 million loss in H1 2023 compared to $0.3 million loss in H1 2022 with the decrease

primarily due to lower realized sulfuric acid prices, which were partially offset by higher sales volumes and lower selling, general

and administrative expenses; and

 On June 28, 2023, the Company filed the NI 43-101 te chnical report for the Farim Phosphate Project; and

 The Special Committee of the Board of Directo rs continues to evaluate strategic alternatives that may be available to company

in an effort to enhance shareholder value.

Market Outlook

2023 prices have moderated off the historically high 2022 prices and weaker global demand drove a significant reduction in Q2 2 023

prices. Due to the nature of our MAP sales contract, with sale s price determined by a three-mont h lagging average, the impact o f this

decrease, coupled with a lower SPA reset pricing, will impact the Company's performance in Q3 2023. The Company expects relativ ely

stable global agriculture and phosphate fertilizer fundamentals moving forward but has seen demand and pricing improve in early Q3

2023 driven by tighter US supply fundamentals. Accordingly, th e Company expects some volatility in pricing in the short term wi th

consistent volume fundamentals in the phosphate fertilizer markets and expects stabilization in pricing long term.

Specific factors the Company expects to support strength in the global phosphate fertilizer markets through 2023 are as follows:

 no significant phosphate supply capacity additions;

 excellent farmer affordability due to sustained high crop prices

 improved phosphate application following lower demand associated with historically high pricing; and

 ongoing phosphate export restrictions from China compared to recent norms.

The Company expects the sulfur an d sulfuric acid markets to remain under pressure globally through 2023 due to increased refine ry

activity and softer demand from phosphate producers and metals consumers.

4Timeline for H1/NDR based on management esti mates and subject to certain assumpti ons, including successful permitting and devel opment activities.

The H1/NDR mine life extension is based on a Preliminary Econom ic Assessment (“2019 PEA”) included in the Conda Technical Repor t (as defined

below). The 2019 PEA on the H1 and NDR properties is preliminary in nature and includes inferred mineral resources that are considered too speculative

geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty

that the 2019 PEA will be realized. Readers are referred to t he Conda Technical Report for the applicable qualifications and as sumptions in connection

with its 2019 PEA.

Financial Outlook

The Company lowered its guidance for 2023 as follows:

(in millions of US Dollars        Projected

except as otherwise noted)      FY 2023

Adjusted EBITDA    $ 115‐135

Net income    45‐60

Basic earnings (C$/share)    0.31‐0.41

Maintenance capex    15‐25

Growth capex    35‐45

Free cash flow    65‐85

Business Outlook

The Company continues to focus on the following key objectives to drive long-term value and shareholder returns:

 improving financial and operational performance;

 deleveraging the balance sheet;

 executing on the requisite infrastr ucture and civil works required for the mine development for H1/NDR; and

 conducting the strategic review process (including evaluating potential strategic alternatives for the company as outlined in the

news release dated March 13, 2023).

About Itafos

The Company is a phosphate and specialty fertilizer company. The Company’s businesses and projects are as follows:

 Conda – a vertically integrated phosphate fertilizer business loca ted in Idaho, US with production capacity as follows:

- approximately 550kt per year of monoammonium phosphate (“M AP”), MAP with micronutrients (“MAP+”), superphosphoric

acid (“SPA”), merchant grade phosphoric acid (“MGA”) and ammonium polyphosphate (“APP”); and

- approximately 27kt per year of hy drofluorosilicic acid (“HFSA”);

 Arraias – a vertically integrated phosphate fertilizer business lo cated in Tocantins, Brazil with production capacity as follows:

- approximately 500kt per year of single superphosph ate (“SSP”) and SSP with micronutrients (“SSP+”); and

- approximately 40kt per year of excess sulfuric acid (220kt per year gross sulfuric acid production capacity);

 Farim – a high-grade phosphate mine project located in Farim, Guinea-Bissau;

 Santana – a vertically integrated high- grade phosphate mine and fertilizer plant project located in Pará, Brazil; and

 Araxá – a vertically integrated rare earth elements and niobium mine and extraction plant project located in Minas Gerais, Brazil.

In addition to the businesses and projects described above, the Co mpany also owns Mantaro (Junin, Peru), which is a phosphate m ine

project that is in process of being wound down.

The Company is a Delaware corporation that is headquartered in Houston, TX. The Company’s shares trade on the TSX Venture

Exchange (“TSX-V”) under the ticker symbol “IFOS”. The Company’s principal shareholder is CL Fertilizers Holding LLC (“CLF”). CLF is

an affiliate of Castlelake, L.P., a global private investment firm.

For more information, or to join the Comp any’s mailing list to receive notification of future news releases, please visit the C ompany’s

website at www.itafos.com.

Forward-Looking Information

Certain information contained in this news release constitutes forward-looking information, including statements with respect to: the timing

for commencement of operations at H1 / N DR; the expected resource life of H1 / ND R; the sources of f unding to be used for the

development of H1 / NDR; economic and market trends with respect to the global agriculture and p hosphate fertilizer markets. Al l

information other than information of histor ical fact is forward-looking information . Statements that address activities, event s or

developments that the Company believes, expects or anticipates will or may occur in the future include, but are not limited to, statements

regarding estimates and/or assumptions in respect of the Company’s financial and business outlook are forward-looking information. The

use of any of the words “intend”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “would”, “believe”,

“predict” and “potential” and similar expressions are intended to identify forward-looking information.

The forward-looking information contained in this news release is based on the opinions, assumptions and estimates of management set

out herein, which management believes are reasonable as at t he date the statements are made. Those opinions, assumptions and

estimates are inherently subject to a variety of risks and uncert ainties and other known and unknow n factors that could cause a ctual

events or results to differ materially from those projected in the forward-looking information. These include the Company’s expectations

and assumptions with respect to the following: commodity prices; operating results; safety risks; changes to the Company’s mine ral

reserves and resources; risk that timing of expected permitting will not be met; changes to mine development and completion; fo reign

operations risks; changes to regulation; environmental risks; t he impact of adverse weather and climate change; general economi c

changes, including inflation and foreign exchange rates; the actions of the Company’s competitors and counterparties; financing, liquidity,

credit and capital risks; the loss of key personnel; impairment risks; cybersecurity risks; risks relating to transportation and infrastructure;

changes to equipment and suppliers; adverse litigation; changes to permitting and licensing; loss of land title and access rights; changes

to insurance and uninsured risks; the potential for malicious acts; market volatility; changes to technology; changes to tax la ws; the risk

of operating in foreign jurisdictions; and the risks posed by a controlling shareholder and other conflicts of interest. Readers are cautioned

that the foregoing list of risks, uncertainties and assumptions is not exhaustive.

Although the Company has attempted to identify crucial factors that could cause actual actions, events or results to differ materially from

those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated,

estimated or intended. Additional risks and uncertainties affecting the forward-looki ng information contained in this news rele ase are

described in greater detail in the Company’s current Annual Information Form and current Management’s Discussion and Analysis

available under the Company’s profile on SEDAR+ at www.sedarplus.com and on the Company’s website at www.itafos.com. There can

be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from

those anticipated in such information. The reader is cautioned not to place undue reliance on forward-looking information. The Company

undertakes no obligation to update forward-l ooking statements if circumst ances or management’s estimates, assumptions or opinions

should change, except as required by applicable securities law. The forward-looking information included in this news release is expressly

qualified by this cautionary statement and is made as of the date of this news release.

This news release contains future oriented financial information and financial outlook information (together, “FOFI”) about the Company’s

prospective results of operations, includi ng statements regarding expected adjusted EBITD A, net income, basic earnings per shar e,

maintenance capex, growth capex and free cash flow. FOFI is subject to the same assumptions, risk factors, limitations and qualifications

as set forth in the above paragraph. The Company has included the FOFI to provide an outlook of management’s expectations regarding

anticipated activities and results, and such information may no t be appropriate for other purposes. The Company and management

believe that the FOFI has been prepared on a reasonable basis, reflecting management’s reasonable estimates and judgements;

however, actual results of operations and the resulting financial results may vary from the amounts set forth herein. Any financial outlook

information speaks only as of the date on which it is made and th e Company undertakes no obligation to publicly update or revis e any

financial outlook information except as required by applicable securities laws.

NEITHER THE TSX-V NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX-

V) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.

For further information, please contact:

Matthew O’Neill

Itafos Investor Relations

[email protected]

713-242-8446

Scientific and Technical Information

The scientific and technical information contained in this news release related to Mineral Resources for Conda and Farim has be en

reviewed and approved by Jerry DeWolfe, Professional Geologist (P.Geo.) with the Association of Professional Engineers and

Geoscientists of Alberta. Mr. DeWolfe is a full-time employee of WSP Canada Inc. and is independent of the Company. The scientific and

technical information contained in this news release related to Mineral Reserves for Conda and Farim has been reviewed and approved

by Edward Minnes, Professional Engineer (P.E.) licensed by the State of Missouri. Mr. Minnes is a part-time employee of WSP USA Inc.

and is independent of the Company. The Company’s latest technical report in respect of Conda is entitled, “NI 43-101 Technical Report

on Itafos Conda and Paris Hills Mineral Projects, Idaho, USA,” with an effective date of July 1, 2019 (the “Conda Technical Report”) and

is available under the Company’s website at www.itafos.com and under the Company’s profile on SEDAR+ at www.sedarplus.com

Non-IFRS Financial Measures

This press release contains both IFRS and certain non-IFRS m easures that management consi ders to evaluate the Company’s

operational and financial performance. Non-IFRS measures are a numerical measure of a company’s performance, that either include or

exclude amounts that are not normally includ ed or excluded from the most directly co mparable IFRS measures. Management believes

that the non-IFRS measures provide useful supplemental information to investors, analysts, lenders and others. In evaluating non-IFRS

measures, investors, analysts, lenders and others should consider that non-IFRS measures do not have any standardized meaning under

IFRS and that the methodology applied by t he Company in calculating such non-IFRS measures may differ among companies and

analysts. Non-IFRS measures should not be considered as a substitute for, nor superior to, measures of financial performance prepared

in accordance with IFRS. Definitions and reconciliations of non-IFRS measures to the most directly comparable IFRS measures are

included below.

DEFINITIONS

The Company defines its non-IFRS measures as follows:

Non-IFRS

measure

Definition Most directly comparable IFRS

measure

Why the Company uses the

measure

EBITDA Earnings before interest, taxes,

depreciation, depletion and

amortization

Net income (loss) and operating income

(loss)

EBITDA is a valuable indicator of

the Company’s ability to generate

operating income

Adjusted EBITDA EBITDA adjusted for non-cash,

extraordinary, non-recurring and other

items unrelated to the Company’s core

operating activities

Net income (loss) and operating income

(loss)

Adjusted EBITDA is a valuable

indicator of the Company’s ability

to generate operating income

from its core operating activities

normalized to remove the impact

of non-cash, extraordinary and

non-recurring items. The

Company provides guidance on

Adjusted EBITDA as useful

supplemental information to

investors, analysts, lenders, and

others

Trailing 12

months Adjusted

EBITDA

Adjusted EBITDA for the current and

preceding three quarters

Net income (loss) and operating income

(loss) for the current and preceding three

quarters

The Company uses the trailing 12

months Adjusted EBITDA in the

calculation of the net leverage

ratio (non-IFRS measure)

Total capex Additions to property, plant, and

equipment and mineral properties

adjusted for additions to asset

retirement obligations, additions to

right-of-use assets and capitalized

interest

Additions to property, plant and

equipment and mineral properties

The Company uses total capex in

the calculation of total cash capex

(non-IFRS measure)

Maintenance

capex

Portion of total capex relating to the

maintenance of ongoing operations

Additions to property, plant and

equipment and mineral properties

Maintenance capex is a valuable

indicator of the Company’s

required capital expenditures to

sustain operations at existing

levels

Growth capex Portion of total capex relating to the

development of growth opportunities

Additions to property, plant and

equipment and mineral properties

Growth capex is a valuable

indicator of the Company’s capital

expenditures related to growth

opportunities.

Net debt Debt less cash and cash equivalents

plus deferred financing costs (does not

consider lease liabilities)

Current debt, long-term debt and cash

and cash equivalents

Net debt Debt less cash and

cash equivalents plus deferred

financing costs (does not

consider lease liabilities) Current

debt, long-term debt and cash

and cash equivalents Net

debt is a valuable indicator of the

Company’s net debt position as it

removes the impact of deferring

financing costs.

Net leverage ratio Net debt divided by trailing 12 months

Adjusted EBITDA

Current debt, long-term debt and cash

and cash equivalents; net income (loss)

and operating income (loss) for the

current and preceding three quarters

The Company’s net leverage ratio

is a valuable indicator of its ability

to service its debt from its core

operating activities.

Liquidity Cash and cash equivalents plus

undrawn committed borrowing

capacity

Cash and cash equivalents Liquidity is a valuable indicator of

the Company’s liquidity

Free cash flow Cash flows from operating activities,

which excludes payment of interest

expense, plus cash flows from

investing activities less cash growth

capex

Cash flows from operating activities and

cash flows from investing activities

Free cash flow is a valuable

indicator of the Company’s ability

to generate cash flows from

operations after giving effect to

required capital expenditures to

sustain operations at existing

levels. Free cash flow is a

valuable indicator of the

Company’s cash flow available

for debt service or to fund growth

opportunities. The Company

provides guidance on free cash

flow as useful supplemental

information to investors, analysts,

lenders, and others.

EBITDA, ADJUSTED EBITDA AND TRAILING 12 MONTHS ADJUSTED EBITDA

For the three months ended June 30, 2023 and 2022

For the three months ended June 30, 2023, the Company had EBITDA and Adjusted EBITDA by segment as follows:

(unaudited in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Net income (loss) $ 27,198 $ (924) $ 87 $ (5,931) $ 20,430

Finance (income) expense, net 1,578 (135) (5) 3,510 4,948

Current and deferred income tax expense

(recovery) 8,600 — — (2,272) 6,328

Depreciation and depletion 7,198 732 2 48 7,980

EBITDA $ 44,574 $ (327) $ 84 $ (4,645) $ 39,686

Unrealized foreign exchange (gain) loss — (432) (342) 454 (320 )

Share-based payment recovery — — — (98) (98 )

Transaction costs — — — 453 453

Other (income) expense, net (7) (43) 6 — (44 )

Adjusted EBITDA $ 44,567 $ (802) $ (252) $ (3,836) $ 39,677

(unaudited in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Operating income (loss) $ 37,357 $ (1,534) $ (254) $ (4,239) $ 31,330

Depreciation and depletion 7,198 732 2 48 7,980

Realized foreign exchange gain 12 — — — 12

Share-based payment recovery — — — (98) (98 )

Transaction costs — — — 453 453

Adjusted EBITDA $ 44,567 $ (802) $ (252) $ (3,836) $ 39,677

For the three months ended June 30, 2022, the Company had EBITDA and Adjusted EBITDA by segment as follows:

(unaudited in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Net income (loss) $ 47,487 $ (960) $ 80 $ (2,326) $ 44,281

Finance (income) expense, net 1,228 (183) 4 6,609 7,658

Current and deferred income tax expense

(recovery) 11,371 — — (7,310) 4,061

Depreciation and depletion 7,939 545 3 48 8,535

EBITDA $ 68,025 $ (598) $ 87 $ (2,979) 64,535

Unrealized foreign exchange (gain) loss — 1,062 (311) 101 852

Share-based payment recovery — — — (1,204) (1,204 )

Transaction costs — — 35 — 35

Gain on settlement (1,352) — — — (1,352 )

Non-recurring compensation expenses — — — 229 229

Other (income) expense, net 43 (59) (32) 544 496

Adjusted EBITDA $ 66,716 $ 405 $ (221) $ (3,309) $ 63,591

(unaudited in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Operating income (loss) $ 60,164 $ (140) $ (259) $ (2,362) $ 57,403

Depreciation and depletion 7,939 545 3 48 8,535

Realized foreign exchange gain (35) — — (20) (55 )

Share-based payment recovery — — — (1,204) (1,204 )

Transaction costs — — 35 — 35

Gain on settlement (1,352) — — — (1,352 )

Non-recurring compensation expenses — — — 229 229

Adjusted EBITDA $ 66,716 $ 405 $ (221) $ (3,309) $ 63,591